Researchers
Milovanović, Zorka
Results 1-20 of 95
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | The Diagnostics of Disease Relapse Within Five-Year Follow-Up and the Role of Androgen Receptor Expression in Patients with Early Triple-Negative Breast Cancer![]() | Spurnić, Igor | Article | 21M21 |
| 2023 | Prognostic and clinical significance of PD-L1, EGFR and androgen receptor (AR) expression in triple-negative breast cancer (TNBC) patients![]() | Medić-Milijić, Nataša; Jovanić, Irena; Nedeljković, Milica | Conference Paper | Mp. category will be shown later |
| 2023 | Role of claudins 3,4 and 7 in triple negative breast cancer progression![]() | Jovanić, Irena; Nedeljković, Milica | Conference Paper | Mp. category will be shown later |
| 2022 | The Role of TP53 and PTEN tumor suppressor genes in response to different breast cancer treatment modalities![]() | Tanić, Nikola | Conference Paper | Mp. category will be shown later |
| 2022 | The impact of TP53 and PTEN tumor suppressor genes on response to different breast cancer treatment modalities![]() | Tanić, Nikola | Article | Mp. category will be shown later |
| 2022 | The role of c-MYC expression in the diagnostic and clinical confirmation of radiation-induced angiosarcoma![]() | Jovanović Luka | Article | 23M23 |
| 2021 | Histone Deacetylase 7 Gene Overexpression Is Associated with Poor Prognosis of Triple-Negative Breast Cancer Patients![]() | Uzelac, Bojana; Krivokuca, Ana M | Article | 23M23 |
| 2021 | 003 Role of PI3K and mTOR in triple-negative breast cancer![]() | Nedeljković Milica | Conference Paper | Mp. category will be shown later |
| 2021 | Role of PTEN, PI3K, and mTOR in Triple-Negative Breast Cancer![]() | Prvanović, Mirjana | Article | 21M21 |
| 2021 | Friend or foe: ABCG2, ABCC1 and ABCB1 expression in triple-negative breast cancer![]() | Nedeljković, Milica | Article | 21M21 |
| 2020 | Incidence of non-breast cancer neoplasms (non-BCN) diagnosed prior and subsequent to breast cancer (BC): Single institution experience.![]() | Tomasevic, Zorica I | Conference Paper | Mp. category will be shown later |
| 2020 | Sentinel lymph node biopsy in clinically node negative patients with papillary thyroid carcinoma![]() | Marković Ivan | Article | 23M23 |
| 2020 | IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients![]() | Vuletić A. | Article | 21M21 |
| 2019 | Interlaboratory concordance in HER2 testing: Results of a Serbian ring-study![]() | Ivkovic-Kapicl, Tatjana | Article | 23M23 |
| 2019 | Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy![]() | Jevrić, Marko | Article | 21M21 |
| 2019 | Difference in amplification of CCND1 oncogene in triple negative and hormone receptor positive breast cancer![]() | Nedeljković, Milica D. | Conference Paper | Mp. category will be shown later |
| 2019 | Importance of copy number alterations of FGFR1 and c-MYC genes in triple negative breast cancer![]() | Nedeljković, Milica | Article | 22M22 |
| 2019 | The impact of PTEN inactivation on triple-negative breast cancer metastatic spread and prognosis![]() | Nedeljković, Milica D. | Conference Paper | Mp. category will be shown later |
| 2018 | IL-2 AND IL-15 CYTOKINE IN VITRO TREATMENTS - INDUCE NKG2D, CD158A AND CD158B RECEPTOR - EXPRESSION ON T, NKT- LIKE AND NK CELL - LYMPHOCYTE SUBSETS FROM REGIONAL LYMPH - NODES OF MELANOMA PATIENTS![]() | Vuletić, Ana M. | Conference Paper | Mp. category will be shown later |
| 2018 | Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma![]() | Milošević, Zorica; Banković, Jasna | Article | 21aM21a |
